Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Nyxoah SA Appoints Liam Kelly as Chief Executive Officer
PUBLIC · NYXHSep 30, 2026
Position
Chief Executive Officer
Company
Nyxoah
Liam Kelly
Mont-Saint-GuibertManufacturingBiotechnologyHealth Care
Description
Liam Kelly will assume the role of CEO at Nyxoah SA effective October 1, 2026, succeeding Olivier Taelman. This leadership transition aligns with the company's strategic focus on US commercialization of its Genio system following FDA approval.
Company Information
Company
Nyxoah
Location
Mont-Saint-Guibert, Walloon Brabant, Belgium
About
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah SA's innovative solution platform is based on the Genio® system, a CE-Mark validated, user-centered neurostimulation therapy for obstructive sleep apnea, the world's most common sleep disordered breathing condition.
Fundz sees it the moment Nyxoah changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.